title: Matrix metalloproteinases as drug targets in ischemia/reperfusion injury.
abstract: Deficient blood supply (ischemia) is a common consequence of some surgical procedures and certain pathologies. Once blood circulation is re-established (reperfusion), a complex series of events results in recruitment of inflammatory cells, rearrangement of the extracellular matrix and induction of cell death, which lead to organ dysfunction. Although ischemia/reperfusion (I/R) injury is an important cause of death, there is no effective therapy targeting the molecular mechanism of disease progression. Matrix metalloproteinases (MMPs), which are important regulators of many cellular activities, have a central role in disease progression after I/R injury, as suggested by numerous studies using MMP inhibitors or MMP-deficient mice. Here, we review the involvement of MMP activity in the various processes following I/R injury and the therapeutic potential of MMP inhibition.
authors: Department for Molecular Biomedical Research, VIB, Ghent, Belgium.
authors: Eline
authors: E
authors: Dejonckheere
authors: Roosmarijn E
authors: RE
authors: Vandenbroucke
authors: Claude
authors: C
authors: Libert
mesh_terms: D000818:Animals; D018450:Disease Progression; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases